Pancreatic overexpression of dominant-negative FGFR1c using the Ipf1/Pdx1 promoter has previously been shown to decrease the number of β-cells, change islets morphology, and to cause diabetes in mice [43]. This evidence concerns the gene PDX1 and diabetes mellitus.